-
1
-
-
3042743794
-
Immunosuppression: Practice and trends
-
Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, R TB, Dyke DB., Immunosuppression: Practice and trends. Am J Transplant 2004; 4 (Suppl 9): 38-53.
-
(2004)
Am J Transplant
, vol.4
, pp. 38-53
-
-
Kaufman, D.B.1
Shapiro, R.2
Lucey, M.R.3
Cherikh, W.S.4
Dyke, D.B.5
-
2
-
-
84864911119
-
Risk factors for native kidney dysfunction in patients with abdominal multivisceral/small bowel transplantation
-
Suzuki M, Mujtaba MA, Sharfuddin AA, et al. Risk factors for native kidney dysfunction in patients with abdominal multivisceral/small bowel transplantation. Clin Transpl 2012; 26: E351-E358.
-
(2012)
Clin Transpl
, vol.26
, pp. E351-E358
-
-
Suzuki, M.1
Mujtaba, M.A.2
Sharfuddin, A.A.3
-
3
-
-
84869494983
-
Impact of tacrolimus-sirolimus maintenance immunosuppression on proteinuria and kidney function in pancreas transplant alone recipients
-
Kandula P, Fridell J, Taber TE, et al. Impact of tacrolimus-sirolimus maintenance immunosuppression on proteinuria and kidney function in pancreas transplant alone recipients. Transplantation 2012; 94: 940-946.
-
(2012)
Transplantation
, vol.94
, pp. 940-946
-
-
Kandula, P.1
Fridell, J.2
Taber, T.E.3
-
4
-
-
0344666767
-
The natural history of chronic allograft nephropathy
-
Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR., The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
-
(2003)
N Engl J Med
, vol.349
, pp. 2326-2333
-
-
Nankivell, B.J.1
Borrows, R.J.2
Fung, C.L.3
O'Connell, P.J.4
Allen, R.D.5
Chapman, J.R.6
-
5
-
-
33745818408
-
Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts
-
quiz following
-
Liptak P, Ivanyi B., Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2006; 2: 398-404; quiz following.
-
(2006)
Nat Clin Pract Nephrol
, vol.2
, pp. 398-404
-
-
Liptak, P.1
Ivanyi, B.2
-
6
-
-
84879133885
-
Pancreas transplant outcomes for United States and non United States cases as reported to the United Network for Organ Sharing and the International Pancreas Transplant Registry as of December 2011
-
Gruessner AC, Gruessner RW., Pancreas transplant outcomes for United States and non United States cases as reported to the United Network for Organ Sharing and the International Pancreas Transplant Registry as of December 2011. Clin Transpl 2012; 26: 23-40.
-
(2012)
Clin Transpl
, vol.26
, pp. 23-40
-
-
Gruessner, A.C.1
Gruessner, R.W.2
-
7
-
-
0035076928
-
Lessons learned from more than 1,000 pancreas transplants at a single institution
-
Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463-501.
-
(2001)
Ann Surg
, vol.233
, pp. 463-501
-
-
Sutherland, D.E.1
Gruessner, R.W.2
Dunn, D.L.3
-
8
-
-
76949101581
-
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)
-
Vincenti F, Charpentier B, Vanrenterghem Y, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010; 10: 535-546.
-
(2010)
Am J Transplant
, vol.10
, pp. 535-546
-
-
Vincenti, F.1
Charpentier, B.2
Vanrenterghem, Y.3
-
9
-
-
80655139682
-
Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes
-
Rostaing L, Neumayer HH, Reyes-Acevedo R, et al. Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clin J Am Soc Nephrol 2011; 6: 2696-2704.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 2696-2704
-
-
Rostaing, L.1
Neumayer, H.H.2
Reyes-Acevedo, R.3
-
10
-
-
84866284135
-
Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study
-
Grinyo J, Alberu J, Contieri FL, et al. Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study. Transpl Int 2012; 25: 1059-1064.
-
(2012)
Transpl Int
, vol.25
, pp. 1059-1064
-
-
Grinyo, J.1
Alberu, J.2
Contieri, F.L.3
-
11
-
-
23944502334
-
Costimulation blockade with belatacept in renal transplantation
-
Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353: 770-781.
-
(2005)
N Engl J Med
, vol.353
, pp. 770-781
-
-
Vincenti, F.1
Larsen, C.2
Durrbach, A.3
-
12
-
-
79951933190
-
Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: A randomized phase II study
-
Rostaing L, Massari P, Garcia VD, et al. Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: A randomized phase II study. Clin J Am Soc Nephrol 2011; 6: 430-439.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 430-439
-
-
Rostaing, L.1
Massari, P.2
Garcia, V.D.3
-
13
-
-
84864079107
-
Pancreas transplantation in the new millennium: The Indiana University experience
-
Fridell JA, Mangus RS, Powelson JA, Mujtaba MA, Chen JM, Taber TE., Pancreas transplantation in the new millennium: The Indiana University experience. Clin Transpl 2011; 25: 145-156.
-
(2011)
Clin Transpl
, vol.25
, pp. 145-156
-
-
Fridell, J.A.1
Mangus, R.S.2
Powelson, J.A.3
Mujtaba, M.A.4
Chen, J.M.5
Taber, T.E.6
-
14
-
-
33644503909
-
Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients
-
Fioretto P, Sutherland DE, Najafian B, Mauer M., Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int 2006; 69: 907-912.
-
(2006)
Kidney Int
, vol.69
, pp. 907-912
-
-
Fioretto, P.1
Sutherland, D.E.2
Najafian, B.3
Mauer, M.4
-
15
-
-
84856117374
-
Renal function in recipients of pancreas transplant alone
-
Smail N, Paraskevas S, Tan X, Metrakos P, Cantarovich M., Renal function in recipients of pancreas transplant alone. Curr Opin Organ Transplant 2012; 17: 73-79.
-
(2012)
Curr Opin Organ Transplant
, vol.17
, pp. 73-79
-
-
Smail, N.1
Paraskevas, S.2
Tan, X.3
Metrakos, P.4
Cantarovich, M.5
-
16
-
-
79251513317
-
Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients
-
Fioretto P, Najafian B, Sutherland DER, Mauer M., Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. Clin J Am Soc Nephrol 2011; 6: 101-106.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 101-106
-
-
Fioretto, P.1
Najafian, B.2
Sutherland, D.E.R.3
Mauer, M.4
-
17
-
-
77954087388
-
Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: An analysis of the organ procurement transplant network/united network of organ sharing database
-
Poommipanit N, Sampaio MS, Cho Y, et al. Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: An analysis of the organ procurement transplant network/united network of organ sharing database. Transplantation 2010; 89: 1496-1503.
-
(2010)
Transplantation
, vol.89
, pp. 1496-1503
-
-
Poommipanit, N.1
Sampaio, M.S.2
Cho, Y.3
-
18
-
-
80054746860
-
Calcineurin inhibitors in kidney transplantation: Friend or foe
-
Casey MJ, Meier-Kriesche HU., Calcineurin inhibitors in kidney transplantation: Friend or foe ? Curr Opin Nephrol Hypertens 2011; 20: 610-615.
-
(2011)
Curr Opin Nephrol Hypertens
, vol.20
, pp. 610-615
-
-
Casey, M.J.1
Meier-Kriesche, H.U.2
-
19
-
-
77949903275
-
Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation
-
Knight RJ, Podder H, Kerman RH, et al. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation. Transplantation 2010; 89: 727-732.
-
(2010)
Transplantation
, vol.89
, pp. 727-732
-
-
Knight, R.J.1
Podder, H.2
Kerman, R.H.3
|